Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Characterizing Alzheimer's disease using a hypometabolic convergence index., , , , , , , , , and 10 other author(s). NeuroImage, 56 (1): 52-60 (2011)A Comparison of Word2Vec, HMM2Vec, and PCA2Vec for Malware Classification., , and . CoRR, (2021)Interdisciplinary Minor in Bioinformatics: First Results and Outlook., , , , and . SIGCSE, page 407-412. ACM, (2020)Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging., , , , , , , and . NeuroImage, 49 (1): 169-176 (2010)Corrigendum to Ässociation between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers" NeuroImage 54/3 (2011) 1896-1902., , , , , , , , , and 9 other author(s). NeuroImage, 58 (3): 974 (2011)Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions., , , , , , , , , and 1 other author(s). NeuroImage, 40 (3): 1214-1221 (2008)Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares., , , , , , , , , and 1 other author(s). NeuroImage, 60 (4): 2316-2322 (2012)Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative., , , , , , , , , and 7 other author(s). NeuroImage, 51 (2): 654-664 (2010)Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers., , , , , , , , , and 9 other author(s). NeuroImage, 54 (3): 1896-1902 (2011)Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)., , , , , , , , , and 3 other author(s). NeuroImage, 45 (4): 1107-1116 (2009)